Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
COVID: full-pipeline trial registry
5 of 15 indexed COVID trials are currently recruiting.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 5 currently recruiting · #1,140 of 28,707 conditions by registered trial count
COVID: 15 US clinical trials tracked, 5 recruiting.
COVID is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Minnesota, running 3 of these trials.
Enrollment posture brief
Registry condition covid
OPEN 5 | RECR 33% | LATE 2 | EARLY 2 | RANK #1140 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
COVID lists 5 open slots (33% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for COVID on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
COVID is recruiting below its size-band peers.
5 of 15 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates COVID research.
University of Minnesota accounts for 3 of 15 trials (20%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical COVID enrolment sits around 461 participants.
Median target enrolment is 461 among the 15 trials that report a genuine target (sentinel values excluded). 2 of those (13.3%) plan for fewer than 100 participants.
-
COVID research leans observational.
6 interventional and 9 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
BioFire Defense
NCT07221097
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
Aptitude Medical Systems
NCT06744660
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
University of Minnesota
NCT04910269
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
University of California, San Francisco
NCT04362150
A Study to Explore the Role of Gut Flora in COVID-19 Infection
ProgenaBiome
NCT04359836
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
University of California, San Francisco
NCT04388605
COVID-19 Biorepository
University of Kansas Medical Center
NCT04568148
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
University of Utah
NCT04467931
Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
University of Minnesota
NCT04546581
Evaluation of Antibody Tests for COVID-19
Washington University School of Medicine
NCT04360954
Early Short Course Corticosteroids in COVID-19
Henry Ford Health System
NCT04374071
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
Hospital for Special Surgery, New York
NCT04389294
Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)
University of Minnesota
NCT04339998
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Apellis Pharmaceuticals
NCT04402060
Convalescent Plasma in the Treatment of COVID 19
Trinity Health Of New England
NCT04343261
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on COVID records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on COVID trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this COVID page
15 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 COVID trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Minnesota sponsors the most COVID trials on record, review their full trial history before evaluating a specific study. See University of Minnesota's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This COVID condition card totals 15 registered trials; most-linked intervention Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.